Abel M S, Villegas F, Abreu J, Gimino F, Steiner S, Beer B, Meyerson L R
Brain Res Bull. 1983 Dec;11(6):729-34. doi: 10.1016/0361-9230(83)90015-1.
The relationship between rapid eye movement sleep deprivation (REMD) and rat beta-adrenergic receptors was evaluated. REMD was achieved using the platform method and verified by EEG and EMG recordings. Although the amount of REM sleep was diminished 90%, there was no alteration in either the number of binding sites or their affinity for [3H]-dihydroalprenolol. Periods of stress as well as recovery periods after REMD were also without effect on the cortical beta-adrenergic receptors. Thus no support is garnered for the interaction of REMD and the cortical beta-adrenergic receptor binding parameters, although REMD is sometimes used as a mode of therapy for depression and other antidepressives do in fact affect the beta-adrenergic system. The mechanism of REMD as a potential antidepressive therapy is yet to be elucidated.
评估了快速眼动睡眠剥夺(REMD)与大鼠β-肾上腺素能受体之间的关系。采用平台法实现快速眼动睡眠剥夺,并通过脑电图和肌电图记录进行验证。尽管快速眼动睡眠量减少了90%,但结合位点的数量或其对[3H]-二氢阿普洛尔的亲和力均未改变。应激期以及快速眼动睡眠剥夺后的恢复期对皮质β-肾上腺素能受体也没有影响。因此,尽管快速眼动睡眠剥夺有时被用作抑郁症的一种治疗方式,且其他抗抑郁药确实会影响β-肾上腺素能系统,但并未获得支持快速眼动睡眠剥夺与皮质β-肾上腺素能受体结合参数相互作用的证据。快速眼动睡眠剥夺作为一种潜在抗抑郁治疗的机制尚待阐明。